By Sean Moloughney, Editor05.31.22
Senate Health, Education, Labor and Pensions (HELP) Committee Chair Senator Patty Murray (D-WA), and Ranking Member Senator Richard Burr (R-NC), officially introduced the FDA Safety and Landmark Advancements (FDASLA) Act, including language to mandate product listing of dietary supplements. The committee had previously released a discussion draft of the bill.
The legislation reauthorizes FDA’s prescription drug, generic drug, biosimilar, and medical device user fee agreements and is considered must-pass legislation. However, the House of Representatives Energy and Commerce Committee version of the FDA user fee package does not include the mandatory product listing provision.
The
The legislation reauthorizes FDA’s prescription drug, generic drug, biosimilar, and medical device user fee agreements and is considered must-pass legislation. However, the House of Representatives Energy and Commerce Committee version of the FDA user fee package does not include the mandatory product listing provision.
The
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
